Transcript Use of Pharmacoeconomics & Outcomes Research Information

Use of Pharmacoeconomics &
Outcomes Research Information in
Health Care Decisions – SURVEY
Results
Peter K Wong, PhD, MS, MBA, RPh
Steve Marx, PharmD, MS
Stephen L. Priori and the Editorial Board of ISPOR
CONNECTIONS
This is a joint project of ISPOR CONNECTIONS and the Health Care Decisions Using
Outcomes Research SIG
The aim of this project is to bridge the understanding between
pharmacoeconomics & outcomes researchers and decision makers
Question #1

Do you consider
yourself a drug, medical
device or diagnostic
treatment decision
maker?
70%
60%
50%
40%



Yes-34.43%
No-65.57%
42 out 122 responded
with Yes

For the rest of the
survey, N is equal to 42
30%
20%
10%
0%
Yes
No
Question #2

How long
have you
been a
decision
maker?
40%
35%
30%
25%
20%
15%
10%
5%
0%
Less
than 1
year
1-5 years
6-10
years
11-15
years
16-20
years
> 20
years
Question #3
0%
Health Care Administrator-Health Plan
Health Care Decision Maker-Government
Health Care Administrator-Hospital
Practicing Physician
Practicing Pharmacist
Pharmacy and Therapeutic Committee Member
Technology Assessment Committee Member
Other
What is your current
occupation?
5%
10%
15%
20%
25%
30%
Question #4
In which country do you reside?
45%
40%
35%
30%
25%
20%
15%
10%
5%
er
th
O
lia
tr a
Au
s
ce
Fr
an
pa
n
Ja
C
hi
na
y
an
er
m
in
g
K
d
U
ni
te
G
do
m
ad
a
C
an
U
SA
0%
Question #5
Please describe your residing country's
health care financing method(s).
70%
60%
50%
40%
30%
20%
10%
0%
er
y
o
pl
al
u
vid
ed
..
r
.
by
so
i
n
,
d
t
y
in
b
e
em
po
k
,
,
s
d
c
o
ce
ce
er
de
p
n
n
y
n
f
a
a
lo
fu
ur
-o
ur
p
t
t
s
s
m
in
en
ou
in
e
,
e
m
e
at
ay
at
rn
0%
v
p
v
i
e
i
0
r
f
r
l
1
P
ov
P
G
Se
...
x
ta
er
th
O
Question #6
In your residing country, who has the authority to make
drug, medical device, or diagnostics treatment
reimbursement decisions that will impact patient care?
Other
Patients
Direct Care Providers
Pharmacy and Therapeutic Committee
Regional Insurance Health Plan
National Insurance Health Plan
Regional Government
National Government
0% 10% 20% 30% 40% 50% 60% 70% 80%
Question #7
Please indicate if your employer has any of these committees
whose function is to assess and select drug, medical device, or
diagnostics treatments at a national, regional or local level?
0%
Pharmacy and
Therapeutic
Committee
Technology
Assessment
Committee
Other
10%
20%
30%
40%
50%
60%
70%
80%
Question #8
Referring to the last question, on which
committee are you a member?
50%
45%
40%
35%
30%
25%
20%
15%
10%
5%
0%
Other
None
Pharmacy and
Therapeutic
Committee
Technology
Assessment
Committee
en
e
An
no
m
ics
al
ys
ity
is
A
Bu
na
Q
r
lys
de
ua
is
n
lity
of
Ad
I ll
C
ne
ju
os
ss
s
tM
te
d
in
Li
im
fe
i
za
.. .
O
ut
t
io
co
n
m
C
An
os
es
...
t -E
R
es
ffe
ea
ct
iv
rc
en
h
es
s
C
A.
H
o
st
ea
..
-o
lth
f -I
R
lln
Pa
el
es
at
tie
s
e
nt
d
Q
Re
ua
po
li..
rt e
d
O
u.
..
fit
oe
co
-U
t il
-B
os
t
os
t
ac
ar
m
C
C
Ph
Question #9
Have you read any articles that have used
any of these terms?
100%
90%
80%
70%
60%
50%
40%
Question #10
Do you have any training in the areas listed below? (The term
training in this survey refers to as 'formal schooling, attended
courses, worked with an expert, or read extensively)
95% Answered Yes
.. .
O
at
ut
io
co
n
m
C
An
os
es
...
t -E
R
e
ffe
se
ct
ar
iv
ch
en
es
s
C
A.
H
o
s
ea
..
t -o
lth
f -I
R
lln
Pa
el
es
a
tie
t
s
e
nt
d
Q
Re
ua
po
li..
rt e
d
O
u.
..
Li
fe
st
ed
M
in
im
Ad
ju
os
t
C
iz
I ll
ne
ss
is
of
lity
rd
en
An
al
ys
is
lys
ity
Bu
Q
ua
C
os
t
-U
t il
fit
en
e
-B
os
t
C
ar
m
ac
oe
co
no
An
a
m
ics
100%
90%
80%
70%
60%
50%
40%
30%
20%
Ph

Question #11


Referring to the last
question, in your
opinion, did the
training help you in
your decisions in
selecting the
appropriate drug,
medical device or
diagnostics
treatment?
Note: Two did not
respond at all
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Yes
No
No Opinion
th
R
at
io
el
a
li..
s
..
es
Q
ua
-o
f -I
lln
te
d
os
t
...
A.
An
s
n
.. .
ne
ss
Li
fe
I ll
en
es
tiv
C
of
is
al
ys
al
ys
is
An
An
st
ed
iz
in
im
Ad
ju
rd
en
-E
ffe
c
M
lity
ea
l
os
t
os
t
H
C
C
Q
ua
Bu
fit
ity
en
e
-B
os
t -U
t il
os
t
C
C
Question #12
Which types of analysis have you used to
make health decisions?
•86% responded with Yes
80%
70%
60%
50%
40%
30%
20%
10%
0%
Question #13
Have you conducted or participated in any studies using
these pharmacoeconomics and outcomes research
methods?
•79% responded Yes
el
a
te
d
Q
ua
li..
es
s
-o
f -I
lln
..
A.
s
os
t
R
th
ea
l
H
os
t
C
C
-E
ffe
c
tiv
en
es
An
...
n
iz
in
im
C
os
t
M
lity
Q
ua
at
io
st
ed
Ad
ju
rd
en
of
I ll
Li
fe
.. .
ne
ss
s
lys
i
An
a
Bu
-U
t il
os
t
C
C
os
t -B
en
e
fit
ity
An
a
lys
is
70%
60%
50%
40%
30%
20%
10%
0%
Question #14

In your last drug,
medical device or
diagnostics
treatment decision,
was pharmacoeconomics and/or
outcomes research
information
considered?
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Yes
No
No opinion
Question #15

Do you routinely use
the pharmacoeconomics and
outcomes research
information to make
drug, medical
device, or diagnostic
treatment decisions?
80%
70%
60%
50%
40%
30%
20%
10%
0%
Yes
No
M
Ad
ju
th
R
Q
ua
li..
s
..
es
A.
-o
f -I
lln
te
d
os
t
s
...
rc
h
An
es
ea
n
.. .
ne
ss
Li
fe
I ll
en
es
el
a
C
R
es
at
io
iz
tiv
-E
ffe
c
ea
l
os
t
m
of
is
al
ys
al
ys
is
An
An
st
ed
rd
en
in
im
lity
O
ut
co
os
t
H
C
C
Q
ua
Bu
fit
ity
en
e
-B
os
t -U
t il
os
t
C
C
Question #16
In your opinion, which method(s) provide you with the
best information to make your drug, medical device, or
diagnostic treatment decisions
70%
60%
50%
40%
30%
20%
10%
0%
Question #17
As a decision maker, do you feel you have been provided with
adequate pharmacoeconomics and outcomes research information
to make drug, medical device, or diagnostics treatment decisions?
50%
45%
40%
35%
30%
25%
20%
15%
10%
5%
0%
Totally inadequate
Somewhat
inadequate
Adequate
information
Too much
information